Neural Regeneration Research ›› 2024, Vol. 19 ›› Issue (2): 324-330.doi: 10.4103/1673-5374.379042

Previous Articles     Next Articles

A review of the neurotransmitter system associated with cognitive function of the cerebellum in Parkinson’s disease

Xi Chen1, 2, Yuhu Zhang1, *   

  1. 1Department of Neurology, Guangdong Neuroscience Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong Province, China; 2Shantou University Medical College, Shantou, Guangdong Province, China
  • Online:2024-02-15 Published:2023-08-30
  • Contact: Yuhu Zhang, MD, yhzhangsd@126.com.
  • Supported by:
    This work was supported by the National Natural Science Foundation of China, No. 82071419; Key Research and Development Program of Guangzhou, No. 202206010086; High-level Hospital Construction Project, No. DFJH201907; and Supporting Research Funds for Outstanding Young Medical Talents in Guangdong Province, No. KJ012019442 (all to YZ).

Abstract: The dichotomized brain system is a concept that was generalized from the ‘dual syndrome hypothesis’ to explain the heterogeneity of cognitive impairment, in which anterior and posterior brain systems are independent but partially overlap. The dopaminergic system acts on the anterior brain and is responsible for executive function, working memory, and planning. In contrast, the cholinergic system acts on the posterior brain and is responsible for semantic fluency and visuospatial function. Evidence from dopaminergic/cholinergic imaging or functional neuroimaging has shed significant insight relating to the involvement of the cerebellum in the cognitive process of patients with Parkinson’s disease. Previous research has reported evidence that the cerebellum receives both dopaminergic and cholinergic projections. However, whether these two neurotransmitter systems are associated with cognitive function has yet to be fully elucidated. Furthermore, the precise role of the cerebellum in patients with Parkinson’s disease and cognitive impairment remains unclear. Therefore, in this review, we summarize the cerebellar dopaminergic and cholinergic projections and their relationships with cognition, as reported by previous studies, and investigated the role of the cerebellum in patients with Parkinson’s disease and cognitive impairment, as determined by functional neuroimaging. Our findings will help us to understand the role of the cerebellum in the mechanisms underlying cognitive impairment in Parkinson’s disease.

Key words: anterior brain system, cerebellum, cholinergic, cognitive impairment, dopaminergic, dual syndrome hypothesis, neuroimage, neurotransmitter, Parkinson’s disease, posterior brain system, therapeutic targets